These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23324976)

  • 21. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.
    Ali H; Guy RJ; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Donovan B
    BMC Infect Dis; 2013 Mar; 13():140. PubMed ID: 23506489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
    Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
    Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years.
    Petráš M; Adámková V
    Vaccine; 2015 Nov; 33(46):6264-7. PubMed ID: 26431981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
    Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS
    Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine.
    Nsouli-Maktabi H; Ludwig SL; Yerubandi UD; Gaydos JC
    MSMR; 2013 Feb; 20(2):17-20. PubMed ID: 23461306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.
    Sonnenberg P; Tanton C; Mesher D; King E; Beddows S; Field N; Mercer CH; Soldan K; Johnson AM
    Sex Transm Infect; 2019 Aug; 95(5):386-390. PubMed ID: 30723185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
    Fernandes C; Alves J; Rodrigues A; Azevedo J;
    Vaccine; 2022 Jan; 40(2):275-281. PubMed ID: 34953608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
    Mariani L; Vici P; Suligoi B; Checcucci-Lisi G; Drury R
    Adv Ther; 2015 Jan; 32(1):10-30. PubMed ID: 25620536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E; Ploner A; Sparén P
    Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
    Canvin M; Sinka K; Hughes G; Mesher D
    Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.
    Liu B; Donovan B; Brotherton JM; Saville M; Kaldor JM
    Sex Transm Infect; 2014 Nov; 90(7):532-7. PubMed ID: 24570485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of Korean adolescent girls.
    Cho J; Kim EM; Kim J; Shin JY; Kim EH; Park JH; Kwon SL; Kwon GY; Shin SA; Kim J
    Epidemiol Health; 2024; 46():e2024040. PubMed ID: 38549356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.
    Mikolajczyk RT; Kraut AA; Horn J; Schulze-Rath R; Garbe E
    Sex Transm Dis; 2013 Jan; 40(1):28-31. PubMed ID: 23250300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
    Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
    J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.